BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12959674)

  • 1. Effectiveness of letters to Cape Breton women who have not had a recent Pap smear.
    Johnston GM; Boyd CJ; MacIsaac MA; Rhodes JW; Grimshaw RN
    Chronic Dis Can; 2003; 24(2-3):49-56. PubMed ID: 12959674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based cultural predictors of Pap smear screening in Nova Scotia.
    Johnston GM; Boyd CJ; MacIsaac MA
    Can J Public Health; 2004; 95(2):95-8. PubMed ID: 15074897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of patient and provider reminders on mammography and Papanicolaou smear screening in a large health maintenance organization.
    Somkin CP; Hiatt RA; Hurley LB; Gruskin E; Ackerson L; Larson P
    Arch Intern Med; 1997 Aug 11-25; 157(15):1658-64. PubMed ID: 9250226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of patient reminder letters to promote cancer screening services in women: A population-based study in Wisconsin.
    Reeves MJ; Remington PL
    Prev Med; 1999 Sep; 29(3):202-9. PubMed ID: 10479608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a call/recall system in improving compliance with cervical cancer screening: a randomized controlled trial.
    Buehler SK; Parsons WL
    CMAJ; 1997 Sep; 157(5):521-6. PubMed ID: 9294390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quasi-randomized trial on the effectiveness of an invitation letter to improve participation in a setting of opportunistic screening for cervical cancer.
    de Jonge E; Cloes E; Op de Beeck L; Adriaens B; Lousbergh D; Orye GG; Buntinx F
    Eur J Cancer Prev; 2008 Jun; 17(3):238-42. PubMed ID: 18414195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social and cultural barriers to Papanicolaou test screening in an urban population.
    Behbakht K; Lynch A; Teal S; Degeest K; Massad S
    Obstet Gynecol; 2004 Dec; 104(6):1355-61. PubMed ID: 15572502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a cognition-emotion focused program to increase public participation in Papanicolaou smear screening.
    Park S; Chang S; Chung C
    Public Health Nurs; 2005; 22(4):289-98. PubMed ID: 16150010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for cervical cancer among female physicians and their relatives in Taiwan: a population-based comparative study.
    Chen LS; Huang N; Tsay JH; Wang PJ; Chou YJ; Chou P; Lee CH
    Prev Med; 2007 Jun; 44(6):531-5. PubMed ID: 17467786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. English proficiency and physicians' recommendation of Pap smears among Hispanics.
    De Alba I; Sweningson JM
    Cancer Detect Prev; 2006; 30(3):292-6. PubMed ID: 16844320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing women's participation in Pap smear screening in Australia--how can we tell if the national policy is effective?
    Shelley J; Street A
    Aust Health Rev; 1992; 15(2):190-9. PubMed ID: 10119050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of cervical cancer screening among women in Taiwan.
    Hou SI; Fernandez ME; Baumler E; Parcel GS; Chen PH
    Health Care Women Int; 2003; 24(5):384-98. PubMed ID: 12916144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.